As on Thursday, Century Therapeutics Inc (NASDAQ: IPSC) got off with the flyer as it spiked 13.24% to $2.31, before settling in for the price of $2.04 at the close. Taking a more long-term approach, IPSC posted a 52-week range of $0.34-$2.38.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 18.46%. Meanwhile, its Annual Earning per share during the time was 18.46%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 91.72%. This publicly-traded company’s shares outstanding now amounts to $86.53 million, simultaneously with a float of $58.50 million. The organization now has a market capitalization sitting at $201.91 million.
Century Therapeutics Inc (IPSC) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Century Therapeutics Inc’s current insider ownership accounts for 33.07%, in contrast to 73.85% institutional ownership. According to the most recent insider trade that took place on Dec 22 ’25, this organization’s Chief Scientific Officer bought 58,060 shares at the rate of 0.85, making the entire transaction reach 49,252 in total value, affecting insider ownership by 1,045,087. Preceding that transaction, on Dec 12 ’25, Company’s President and CEO bought 52,000 for 0.58, making the whole transaction’s value amount to 30,352. This particular insider is now the holder of 3,322,990 in total.
Century Therapeutics Inc (IPSC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
Century Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 91.72% and is forecasted to reach -0.52 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 29.46% through the next 5 years, which can be compared against the 18.46% growth it accomplished over the previous five years trading on the market.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
Let’s observe the current performance indicators for Century Therapeutics Inc (IPSC). It’s Quick Ratio in the last reported quarter now stands at 6.25. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.78.
In the same vein, IPSC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.31, a figure that is expected to reach -0.27 in the next quarter, and analysts are predicting that it will be -0.52 at the market close of one year from today.
